For the Inventor, By the Inventor

Enter assignee name

Minneapolis, MN, United States of America

Synerfuse, Inc.

USPTO Granted Patents = 10

Trademarks = 3

Forward Citations = 27

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Gregory F Molnar (10 out of 50 patents)

Justin D Zenanko (9 out of 9 patents)

Nazmi Peyman (9 out of 9 patents)

4. Christopher G Frank (7 out of 7 patents)

5. Beth A Lindborg (7 out of 8 patents)

6. Kyle R Grube (7 out of 7 patents)

7. Michael C Park (7 out of 8 patents)

8. Matthew A Hunt (7 out of 8 patents)

9. Kathy Hill (6 out of 6 patents)

10. Harry A Puryear (2 out of 46 patents)

11. Omid Souresrafil (1 out of 2 patents)

12. Serafin Y Samson (1 out of 1 patent)

13. Timothy J Cox (1 out of 7 patents)

14. Kari W Wright (1 out of 1 patent)

15. Kathleen W Hill (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12721683 - Robotic navigation and guidance system for implanting a neuromodulation device (2026-09-01),

2. 12515041 - Methods and systems for implanting a neuromodulation system at a surgically open spinal treatment site (2026-01-06),

3. 12343524 - Methods and systems for implanting a neuromodulation system and a spinal fixation system at a surgically open spinal treatment site with direct visual and/or physical access to targeted dorsal root ganglion (2025-07-01),

4. 11813467 - Systems, devices and methods for implantable neuromodulation stimulation (2023-11-14),

5. 11638817 - Methods and systems for implanting a neuromodulation system and a spinal fixation system at a surgically open spinal treatment site with direct visual and/or physical access to targeted dorsal root ganglion (2023-05-02),

6. 11471673 - Methods and systems for implanting a neuromodulation system and a spinal fixation system at a surgically open spinal treatment site (2022-10-18),

7. 11247046 - Methods and systems for implanting a neuromodulation system at a surgically open spinal treatment site (2022-02-15),

8. 10933234 - System, devices, and methods combining spinal stabilization and neuromodulation (2021-03-02),

9. 10675458 - Methods and systems for implanting a neuromodulation system and a spinal fixation system at a surgically open spinal treatment site (2020-06-09),

10. 10117580 - Systems, devices and methods that affect neural tissue through the delivery of a pulsed radio frequency signal generated by an implantable medical device (2018-11-06),

Company Overview

Synerfuse, Inc. is a Minneapolis-based company specializing in advanced medical technologies, particularly in the field of orthopedic solutions. The organization focuses on developing innovative products that enhance surgical procedures and improve patient outcomes. With a commitment to research and development, Synerfuse aims to address the evolving needs of healthcare professionals and patients alike, leveraging cutting-edge technology to create effective and reliable medical devices.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#162 in Minneapolis, MN

#850 in Minnesota

#29,866 in US

#56,047 in the World

Minneapolis, MN, United States of America

Synerfuse, Inc.

Forward Citations = 27

15 inventors:

Gregory F Molnar (10 out of 50 patents)

Justin D Zenanko (9 out of 9 patents)

Nazmi Peyman (9 out of 9 patents)

4. Christopher G Frank (7 out of 7 patents)

5. Beth A Lindborg (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synerfuse, Inc.. Retrieved from https://idiyas.com/company/synerfuse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…